Synonyms: Alamast® | Alegysal® | BMY-26517
pemirolast is an approved drug (FDA (1999))
Compound class:
Synthetic organic
Comment: Pemirolast is an antihistamine.
Marketed formulations may contain pemirolast potassium salt (PubChem CID 443866). |
|
No information available. |
Summary of Clinical Use ![]() |
Pemirolast is contained in opthalmic solutions used to treat the symptoms of seasonal allergic conjunctivitis, including itching, redness and swelling. |
Mechanism Of Action and Pharmacodynamic Effects ![]() |
Pemirolast blocks the action of endogenous histamine at histamine H1 receptor. The drug inhibits eosinophil infiltration in the eye and prevents their release of inflammatory mediators. |
External links ![]() |
For extended ADME data see the following: Drugs.com |